Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-26-035916
Filing Date
2026-03-30
Accepted
2026-03-30 06:41:25
Documents
13

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea0282909-424b5_regencell.htm 424B5 574614
2 FILING FEE TABLE ea028290901ex-fee.htm   iXBRL EX-FILING FEES 13551
3 GRAPHIC ea028290901_img1.jpg GRAPHIC 7945
4 GRAPHIC ea028290901_img2.jpg GRAPHIC 7945
  Complete submission text file 0001213900-26-035916.txt   730769

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT ea028290901ex-fee_htm.xml XML 4486
Mailing Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG China
Business Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG China 852 2155 0823
Regencell Bioscience Holdings Ltd (Filer) CIK: 0001829667 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9
Type: 424B5 | Act: 33 | File No.: 333-294722 | Film No.: 26809901
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)